company background image
1734 logo

Sinphar PharmaceuticalLtd TWSE:1734 Stock Report

Last Price

NT$37.10

Market Cap

NT$6.2b

7D

0.4%

1Y

1.2%

Updated

13 Jun, 2024

Data

Company Financials

Sinphar Pharmaceutical Co.,Ltd.

TWSE:1734 Stock Report

Market Cap: NT$6.2b

1734 Stock Overview

Researches, develops, manufactures, and sells therapeutic drugs, health care foods, and medical beauty products in Taiwan, Mainland China, the United States, Vietnam, and internationally.

1734 fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance5/6
Financial Health5/6
Dividends3/6

Sinphar Pharmaceutical Co.,Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Sinphar PharmaceuticalLtd
Historical stock prices
Current Share PriceNT$37.10
52 Week HighNT$41.10
52 Week LowNT$31.10
Beta0.67
1 Month Change2.63%
3 Month Change4.80%
1 Year Change1.23%
3 Year Change22.64%
5 Year Change88.80%
Change since IPO177.32%

Recent News & Updates

Impressive Earnings May Not Tell The Whole Story For Sinphar PharmaceuticalLtd (TWSE:1734)

Apr 02
Impressive Earnings May Not Tell The Whole Story For Sinphar PharmaceuticalLtd (TWSE:1734)

Recent updates

Impressive Earnings May Not Tell The Whole Story For Sinphar PharmaceuticalLtd (TWSE:1734)

Apr 02
Impressive Earnings May Not Tell The Whole Story For Sinphar PharmaceuticalLtd (TWSE:1734)

Would Sinphar PharmaceuticalLtd (TPE:1734) Be Better Off With Less Debt?

Feb 15
Would Sinphar PharmaceuticalLtd (TPE:1734) Be Better Off With Less Debt?

Can You Imagine How Sinphar PharmaceuticalLtd's (TPE:1734) Shareholders Feel About The 52% Share Price Increase?

Dec 22
Can You Imagine How Sinphar PharmaceuticalLtd's (TPE:1734) Shareholders Feel About The 52% Share Price Increase?

Shareholder Returns

1734TW PharmaceuticalsTW Market
7D0.4%0.1%2.5%
1Y1.2%6.5%26.3%

Return vs Industry: 1734 underperformed the TW Pharmaceuticals industry which returned 6.5% over the past year.

Return vs Market: 1734 underperformed the TW Market which returned 26.3% over the past year.

Price Volatility

Is 1734's price volatile compared to industry and market?
1734 volatility
1734 Average Weekly Movement2.8%
Pharmaceuticals Industry Average Movement4.2%
Market Average Movement4.7%
10% most volatile stocks in TW Market8.5%
10% least volatile stocks in TW Market2.2%

Stable Share Price: 1734 has not had significant price volatility in the past 3 months.

Volatility Over Time: 1734's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1977n/an/awww.sinphar.com.tw

Sinphar Pharmaceutical Co.,Ltd., together with its subsidiaries, researches, develops, manufactures, and sells therapeutic drugs, health care foods, and medical beauty products in Taiwan, Mainland China, the United States, Vietnam, and internationally. It operates through three segments: Pharmaceuticals, Healthy Food, and Other. It produces anti-cancer pharmaceuticals, such as injections, solid reagents, and hormone reagents; and tablets, soft gel capsules and powder and canned special nutrient products.

Sinphar Pharmaceutical Co.,Ltd. Fundamentals Summary

How do Sinphar PharmaceuticalLtd's earnings and revenue compare to its market cap?
1734 fundamental statistics
Market capNT$6.16b
Earnings (TTM)NT$405.43m
Revenue (TTM)NT$2.97b

15.3x

P/E Ratio

2.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
1734 income statement (TTM)
RevenueNT$2.97b
Cost of RevenueNT$1.84b
Gross ProfitNT$1.13b
Other ExpensesNT$719.82m
EarningsNT$405.43m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)2.42
Gross Margin37.90%
Net Profit Margin13.65%
Debt/Equity Ratio54.9%

How did 1734 perform over the long term?

See historical performance and comparison

Dividends

2.7%

Current Dividend Yield

41%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.